Protective Effect of Hydroxysafflor Yellow A on Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Rats

被引:0
作者
JIN Ming [1 ]
WANG Lin [1 ]
WU Yan [1 ]
ZANG Bao-xia [1 ]
TAN Li [1 ]
机构
[1] Department of Pharmacology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital,Capital Medical University
关键词
hydroxysafflor yellow A; pulmonary fibrosis; pulmonary inflammation; nuclear factor-κB p65; α-smooth muscle actin; Chinese medicine;
D O I
暂无
中图分类号
R285.5 [中药实验药理];
学科分类号
1008 ;
摘要
Objective: To observe the effect of hydroxysafflor yellow A(HSYA), an active ingredient of a traditional Chinese herbal medicine Carthamus tinctorius L., on lung inflammation and pulmonary fibrosis induced by bleomycin(BLM) in rats. Methods: Animals were divided into 6 groups including normal group, model group, three HSYA groups and dexamethasone(DXM) group. Three doses of HSYA(35.6, 53.3, and 80.0 mg·kg;·day;) were intraperitoneally(i.p.) injected in rats for 3 weeks after BLM administration and DXM was used as the positive control(n=8 or 12). Arterial blood gas was assayed and morphological changes were observed. Lung mRNA expressions of tumor necrosis factor(TNF)-α, interleukin(IL)-1β, IL-6 and some cytokines in lung tissue were detected by real-time polymerase chain reaction. Nuclear factor-κB p65 or α-smooth muscle actin(α-SMA) protein distribution in rat lung tissue was observed by immunohistochemistry. Results: On the 7 th day after BLM administration, lung tissue showed serious inflammation. Treatment with HSYA or DXM ameliorated lung inflammation. After treatment with HSYA or DXM, oxygen partial pressure(PaO;) increased(HSYA 80.0 mg·kg;, P<0.01) and CO;partial pressure(PaCO;) decreased(HSYA 53.3, 80.0 mg·kg;, P<0.05). Moreover, the mRNA expression of TNF-α, IL-1β, and IL-6; and the number of NF-κB p65 positive cells was lower in HSYA 53.3 and 80.0 mg·kg;groups than those in the model group(all P<0.05). Twenty-one days after BLM administration, HSYA or DXM treatment ameliorated fibrosis, increased PaO;(HSYA 53.3, 80.0 mg·kg;, P<0.01), and decreased PaCO;(53.3 and 80.0 mg·kg;, P<0.05). Further, the mRNA expression of TGF-β1, α-SMA, and collagen Ⅰ as well as the number of α-SMA positive cells increased in the model group and HSYA can attenuate these changes(53.3, 80.0 mg·kg;, P<0.05). Hematoxylin and eosin and Masson’s trichrome staining indicated that the fibrosis and collagen deposition were ameliorated in HSYA groups(53.3, 80.0 mg·kg;, P<0.05). Conclusion: HSYA could alleviate acute lung inflammation and chronic pulmonary fibrosis induced by BLM in rats.
引用
收藏
页码:32 / 39
页数:8
相关论文
共 50 条
  • [31] Ameliorative Effects of Atorvastatin on Bleomycin-Induced Pulmonary Fibrosis in Rats
    Hemmeti, Ali Asghar
    Zerafatfard, Mohammad Rahim
    Goudarzi, Mehdi
    Khodayar, Mohammad Javad
    Rezaie, Anahita
    Nooshabadi, Mohammad Reza Rashidi
    Kiani, Milad
    JUNDISHAPUR JOURNAL OF NATURAL PHARMACEUTICAL PRODUCTS, 2016, 11 (04)
  • [32] Protective Effects of Morin Against Bleomycin-Induced Pulmonary Fibrosis in Mice
    Hemmati, Ali Asghar
    Pashmforosh, Marzie
    Tabandeh, Mohammad Reza
    Rezaie, Annahita
    Vardanjani, Hossein Rajabi
    Pipelzadeh, Mohammad Hasan
    Karampour, Neda Sistani
    JUNDISHAPUR JOURNAL OF NATURAL PHARMACEUTICAL PRODUCTS, 2019, 14 (04)
  • [33] Protective effects of Baibu Tang on bleomycin-induced pulmonary fibrosis in mice
    Xie Weina
    Ding Qi
    Sun Jing
    Zhang Chaofeng
    Zhang Mian
    Xu Xianghong
    JOURNAL OF CHINA PHARMACEUTICAL UNIVERSITY, 2018, 49 (04) : 483 - 489
  • [34] Ibrutinib Exacerbates Bleomycin-Induced Pulmonary Fibrosis via Promoting Inflammation
    Gu, Yangyang
    Huang, Bo
    Yang, Yanfei
    Qi, Mengdie
    Lu, Guohua
    Xia, Dajing
    Li, Hequan
    INFLAMMATION, 2018, 41 (03) : 904 - 913
  • [35] Hydroxysafflor Yellow A Alleviates Early Inflammatory Response of Bleomycin-Induced Mice Lung Injury
    Wu, Yan
    Wang, Lin
    Jin, Ming
    Zang, Bao-xia
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2012, 35 (04) : 515 - 522
  • [36] Ibrutinib Exacerbates Bleomycin-Induced Pulmonary Fibrosis via Promoting Inflammation
    Yangyang Gu
    Bo Huang
    Yanfei Yang
    Mengdie Qi
    Guohua Lu
    Dajing Xia
    Hequan Li
    Inflammation, 2018, 41 : 904 - 913
  • [37] Protective Effect of Tunisian Red Seaweed (Corallina officinalis) Against Bleomycin-Induced Pulmonary Fibrosis and Oxidative Stress in Rats
    Dhaouafi, Jihen
    Abidi, Anouar
    Nedjar, Naima
    Romdhani, Montassar
    Tounsi, Haifa
    Sebai, Hichem
    Balti, Rafik
    DOSE-RESPONSE, 2023, 21 (02):
  • [38] Inhibitory effect of compound Chuanxiong Kangxian granules on bleomycin-induced pulmonary fibrosis in rats
    Shi, Weiyi
    Feng, Bo
    Xu, Shuguang
    Shen, Xiaoyun
    Zhang, Tiefeng
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 96 : 1179 - 1185
  • [39] Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats
    Yun-Yan Wan
    Guang-Yan Tian
    Hai-Sheng Guo
    Yan-Meng Kang
    Zhou-Hong Yao
    Xi-Li Li
    Qing-Hua Liu
    Dian-Jie Lin
    Respiratory Research, 14
  • [40] Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats
    Wan, Yun-Yan
    Tian, Guang-Yan
    Guo, Hai-Sheng
    Kang, Yan-Meng
    Yao, Zhou-Hong
    Li, Xi-Li
    Liu, Qing-Hua
    Lin, Dian-Jie
    RESPIRATORY RESEARCH, 2013, 14